Interestingly, most of these strongly staining RTKs were mutually exclusive, evoking the oncogenic driver mutations (EGFR, KRAS, ALK, and ROS1) observed in lung adenocarcinoma. This evidence concerns the gene ROS1 and lung adenocarcinoma.